Table 1.
Comparison of optimal body fluids for single EV analysis in liquid biopsy
| Biofluid | Advantages | Disadvantages | Applications | References |
|---|---|---|---|---|
| Plasma | high EV concentration rich in tEVs widely used clinically |
high background of lipoproteins/proteins co-isolation of contaminants hemolysis may affect results |
cancer diagnostics, biomarker discovery, monitoring treatment | 61 |
| Urine | non-invasive low protein background |
low EV concentration diluted samples variable EV content depending on hydration |
urological cancers | 62 |
| Saliva | non-invasive easy sampling reflects oral and systemic conditions |
low EV concentration high bacterial content contamination with mucins, high viscosity challenges EV isolation |
oral cancers | 63 |
| CSF | high relevance for CNS diseases | invasive collection low volume available |
brain tumors | 64 |
| Pleural/Ascitic Fluids | abundance of tEVs relevant for metastatic cancers |
invasive patient-specific variability |
ovarian, lung, and gastrointestinal cancers | 65 |